MFDS — authorised 16 July 1957
- Marketing authorisation holder: AUXILIUM PHARMS LLC
- Status: likely_approved
🇰🇷 Robaxin in South Korea
MFDS authorised Robaxin on 16 July 1957
Marketing authorisation
Robaxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Robaxin approved in South Korea?
Yes. MFDS authorised it on 16 July 1957.
Who is the marketing authorisation holder for Robaxin in South Korea?
AUXILIUM PHARMS LLC holds the South Korean marketing authorisation.